QIM
RXRX icon

Quantitative Investment Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Quantitative Investment Management’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$326K Buy
+88,878
New +$296K 0.04% 326
2025
Q3 		– Sell
-65,771
Closed -$332K – 470
2025
Q2 		$332K Buy
+65,771
New +$323K 0.04% 242

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Quantitative Investment Management's RXRX Position: Q2 2026 in Review

Quantitative Investment Management opened a new position in Recursion Pharmaceuticals (RXRX) in Q2 2026: 88,878 shares worth $326K. The stake represents 0.04% of the portfolio and ranks #326 among its holdings. This is a return to the name: Quantitative Investment Management previously reported a position in RXRX as recently as Q2 2025.

Quantitative Investment Management first reported a position in RXRX in Q2 2025 and has held it in 2 quarters since. The position peaked at $332K in Q2 2025. 343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • Quantitative Investment Management held 88,878 shares of Recursion Pharmaceuticals worth $326K as of Q2 2026.
  • Recursion Pharmaceuticals was a new Quantitative Investment Management position in Q2 2026.
  • Recursion Pharmaceuticals made up 0.04% of Quantitative Investment Management's portfolio in Q2 2026, its #326 holding.
  • Quantitative Investment Management first reported a position in Recursion Pharmaceuticals in Q2 2025 and has held it in 2 quarters since.
  • Quantitative Investment Management's Recursion Pharmaceuticals position peaked at $332K in Q2 2025.
  • 343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Quantitative Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.